DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zolinza (Vorinostat) - Platelet Count Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Platelet Count Decreased (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zolinza (Vorinostat) where reactions include platelet count decreased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Zolinza side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-27

Patient:

Reactions: Dermatitis Acneiform, Dysgeusia, Malaise, Folliculitis, Platelet Count Decreased, Decreased Appetite, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Anaplastic Large Cell Lymphoma T- and Null-Cell Types
    Start date: 2011-11-21
    End date: 2011-12-05

Zolinza
    Dosage: 300 mg, unk
    Administration route: Oral
    Start date: 2011-12-14

Other drugs received by patient: Loxoprofen; Lansoprazole; Lyrica; Vitamin B12; Mucosta



Possible Zolinza side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Febrile Neutropenia, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Temozolomide
    Dosage: 75 mg/m2, qd
    Administration route: Oral
    Start date: 2012-07-23
    End date: 2012-07-30

Zolinza
    Dosage: 300 mg, on days 1-5, qw
    Administration route: Oral
    Start date: 2012-07-23
    End date: 2012-07-30

Zolinza
    Dosage: 300 mg, on days 1-5, qw
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2012-07-02

Temozolomide
    Dosage: 75 mg/m2, qd
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2012-07-02



Possible Zolinza side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Vomiting, Nausea, Alanine Aminotransferase Increased, Eosinophilic Pneumonia Acute, Parotitis, Constipation, Death, Aspartate Aminotransferase Increased, Platelet Count Decreased, Pleural Effusion, Deep Vein Thrombosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2011-11-10
    End date: 2011-11-21

Zolinza
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-01-02
    End date: 2012-01-14

Zolinza
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2011-11-29
    End date: 2011-12-01

Zolinza
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2011-12-08
    End date: 2011-12-26

Other drugs received by patient: Pantethine; Allegra; Armodafinil; Maglax (Magnesium Oxide); Lantus; Rabeprazole Sodium; Novorapid; Lipitor



Possible Zolinza side effects in 70 year old female

Reported by a individual with unspecified qualification from Japan on 2012-06-12

Patient: 70 year old female

Reactions: Respiratory Disorder, Anaemia, Platelet Count Decreased, Renal Failure Acute, Pyelonephritis, White Blood Cell Count Increased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zolinza

Other drugs received by patient: Olmetec; Lansoprazole; Fosamax; Amlodipine Besylate; Olopatadine HCL; Predonine; Levothyroxine Sodium



Possible Zolinza side effects in 68 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-16

Patient: 68 year old male

Reactions: Platelet Count Decreased, Haemolytic Anaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zolinza
    Dosage: 400 mg/daily 300 mg/daily 200 mg/daily
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2012-02-10
    End date: 2012-02-24

Zolinza
    Dosage: 400 mg/daily 300 mg/daily 200 mg/daily
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2011-11-22
    End date: 2011-12-26

Zolinza
    Dosage: 400 mg/daily 300 mg/daily 200 mg/daily
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2011-12-27
    End date: 2012-02-09

Other drugs received by patient: Prinivil; Tigason; Coniel; Tamsulosin HCL



Possible Zolinza side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-11

Patient: 68 year old female

Reactions: Fibrin Degradation Products Increased, Cardio-Respiratory Arrest, Fibrin D Dimer Increased, Drowning, Platelet Count Decreased, Embolism Venous, Decreased Appetite, Deep Vein Thrombosis, Blood Glucose Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zolinza
    Dosage: 300 mg/daily 200 mg/daily
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2012-02-17
    End date: 2012-02-19

Zolinza
    Dosage: 300 mg/daily 200 mg/daily
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2012-01-31
    End date: 2012-02-14

Zolinza
    Dosage: 300 mg/daily 200 mg/daily
    Administration route: Oral
    Indication: Mycosis Fungoides
    Start date: 2012-02-24
    End date: 2012-02-27

Other drugs received by patient: Mexitil; Prednisolone; Warfarin Sodium; Clonazepam; Lansoprazole; Gabapentin; Mirtazapine; Cotrim; Vepesid; Risedronate Sodium; Lamisil

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017